Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.050
+0.090 (2.27%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 4:26 PM EST
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $275.73 million as of December 20, 2024. Its market cap has decreased by -72.94% in one year.
Market Cap
275.73M
Enterprise Value
43.91M
1-Year Change
-72.94%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $275.73M, a decrease of -74.21%. That is a compound annual growth rate of -36.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 269.61M | -72.87% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 276.13M |
| Procaps Group | 275.29M |
| Sera Prognostics | 274.57M |
| C4 Therapeutics | 271.41M |
| Vanda Pharmaceuticals | 269.97M |
| COMPASS Pathways | 268.21M |
| Zynex | 267.50M |
| Accolade | 267.38M |